Literature DB >> 29325808

Dutch breast reconstruction guideline.

Marc A M Mureau1.   

Abstract

Treatment of breast cancer is complex and multidisciplinary by nature, with protocols that are updated continuously. During preoperative multidisciplinary team meetings, regularly there is discussion between team members regarding optimal timing and type of breast reconstruction, due to conflicting interests of oncological and reconstructive treatments. Therefore, a multidisciplinary, evidence-based guideline for breast reconstruction in women undergoing breast conserving therapy or mastectomy for breast cancer, or following prophylactic mastectomy was developed by a multidisciplinary working group. The guideline was drafted in accordance with the AGREE II instrument, designed to assess the quality of guidelines with broad international support. For the recommendations, scientific evidence was considered together with other key aspects, such as working group member expertise, patient preferences, costs, availability of facilities and/or organizational aspects. Recommendations provide an answer to the primary questions, and are based on the best scientific evidence available together with the most important considerations by the working group. In accordance with the GRADE method, the level of scientific evidence and the importance given to considerations by the working group jointly determined the strength of the recommendation. The guideline aims to provide practical guidance for plastic surgeons and other members of the multidisciplinary breast cancer team. The implementation of the present breast reconstruction guideline may contribute to optimizing the delivery of care and support for breast reconstruction patients, it may stimulate evidence-based plastic surgery, it may reduce undesirable variation in clinical practice between health care providers, and improve the overall quality of life of breast reconstruction patients.
Copyright © 2018 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  breast reconstruction; evidence-based medicine; guideline; outcomes

Mesh:

Year:  2017        PMID: 29325808     DOI: 10.1016/j.bjps.2017.12.020

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  9 in total

1.  Understanding Preoperative Breast Satisfaction among Patients Undergoing Mastectomy and Immediate Reconstruction: BREAST-Q Insights.

Authors:  Meghana G Shamsunder; Thais O Polanco; Colleen M McCarthy; Robert J Allen; Evan Matros; Michelle Coriddi; Babak J Mehrara; Andrea Pusic; Jonas A Nelson
Journal:  Plast Reconstr Surg       Date:  2021-12-01       Impact factor: 4.730

2.  Association between initiation of adjuvant chemotherapy beyond 30 days after surgery and overall survival among patients with triple-negative breast cancer.

Authors:  Erik Heeg; Perla J Marang-van de Mheen; Marissa C Van Maaren; Kay Schreuder; Rob A E M Tollenaar; Sabine Siesling; Monique E M M Bos; Marie-Jeanne T F D Vrancken Peeters
Journal:  Int J Cancer       Date:  2019-11-28       Impact factor: 7.396

3.  Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands.

Authors:  E Heeg; M B Jensen; M A M Mureau; B Ejlertsen; R A E M Tollenaar; P M Christiansen; M T F D Vrancken Peeters
Journal:  Breast Cancer Res Treat       Date:  2020-06-10       Impact factor: 4.872

4.  Patterns of immediate breast reconstruction in New South Wales, Australia: a population-based study.

Authors:  Yingyu Feng; Kathy Flitcroft; Marina T van Leeuwen; Adam G Elshaug; Andrew Spillane; Sallie-Anne Pearson
Journal:  ANZ J Surg       Date:  2019-08-16       Impact factor: 1.872

5.  Predictors of delayed breast reconstruction in the Netherlands: a 5-year follow-up study in stage I-III breast cancer patients.

Authors:  L S E van Egdom; K M de Ligt; L de Munck; L B Koppert; M A M Mureau; H A Rakhorst; S Siesling
Journal:  Breast Cancer       Date:  2021-11-15       Impact factor: 4.239

6.  Does the breast reconstruction method have an impact on time delay to adjuvant chemotherapy - A comparison between autologous and expander/implant breast reconstruction.

Authors:  Monika Lanthaler; Katharina Spechtler; Johanna Krapf; Daniel Egle; Michael Sieb; Christoph Tasch; Rossella Spinelli; Gerhard Pierer; Thomas Bauer
Journal:  JPRAS Open       Date:  2022-06-23

7.  Quality and reporting of clinical guidelines for breast cancer treatment: A systematic review.

Authors:  Marta Maes-Carballo; Luciano Mignini; Manuel Martín-Díaz; Aurora Bueno-Cavanillas; Khalid Saeed Khan
Journal:  Breast       Date:  2020-08-10       Impact factor: 4.380

8.  Nationwide population-based study of the impact of immediate breast reconstruction after mastectomy on the timing of adjuvant chemotherapy.

Authors:  E Heeg; J X Harmeling; B E Becherer; P J Marang-van de Mheen; M T F D Vrancken Peeters; M A M Mureau
Journal:  Br J Surg       Date:  2019-08-06       Impact factor: 6.939

Review 9.  Shared decision making in breast cancer treatment guidelines: Development of a quality assessment tool and a systematic review.

Authors:  Marta Maes-Carballo; Isabel Muñoz-Núñez; Manuel Martín-Díaz; Luciano Mignini; Aurora Bueno-Cavanillas; Khalid Saeed Khan
Journal:  Health Expect       Date:  2020-08-03       Impact factor: 3.377

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.